• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - health tech
Tag:

health tech

Health

Utah medical board calls for ‘suspension’ of AI doctor experiment

by Chief Editor April 25, 2026
written by Chief Editor

The Rise of the AI Doctor: Balancing Innovation with Patient Safety

The healthcare landscape is witnessing a pivotal shift as artificial intelligence moves from administrative support to clinical decision-making. The most provocative example of this trend is the emergence of systems capable of conducting clinical evaluations and managing prescriptions autonomously.

In Utah, an experiment involving the startup Doctronic aimed to deploy a chatbot capable of autonomously renewing prescriptions for nearly 200 different drugs. This move represents a significant leap toward “AI doctors” that operate without direct physician oversight for specific tasks.

Did you recognize? The Utah AI experiment targeted the autonomous renewal of nearly 200 different medications, sparking a major debate over the necessity of human physician oversight.

The Regulatory Collision: Medical Boards vs. AI Rapid Deployment

As AI capabilities expand, a natural tension is forming between tech-driven policy and established medical governance. The Utah Medical Licensing Board recently called for the immediate suspension of the state’s AI prescription program, citing a lack of consultation before the program’s launch.

View this post on Instagram about Utah, Medical
From Instagram — related to Utah, Medical

The core of the conflict lies in risk management. Medical boards argue that proceeding with autonomous AI systems without professional consultation potentially places citizens at risk. This highlights a growing trend where regulatory bodies are scrambling to keep pace with the speed of AI integration in clinical settings.

The Role of the FDA in AI Safety

Beyond state-level boards, there is an ongoing global conversation regarding whether the FDA should be the primary entity ensuring that “AI doctors” are safe for public use. As these tools transition from simple chatbots to diagnostic and prescriptive entities, the demand for standardized safety frameworks is increasing.

Institutional Adaptation: How Hospitals are Fighting Back

While some state governments experiment with autonomous systems, health systems are taking a different approach to AI. Rather than allowing patients to rely on general-purpose AI like ChatGPT, many hospitals are deploying their own specialized chatbots.

Institutional Adaptation: How Hospitals are Fighting Back
Hospitals Utah

This strategy allows institutions to maintain a level of control over the information provided to patients while still leveraging the efficiency of conversational AI. We are also seeing more strategic partnerships, such as the deal between OpenEvidence and a major health system, to integrate high-quality evidence into clinical workflows.

Pro Tip: For healthcare providers, the key to integrating AI is focusing on “human-in-the-loop” systems—where AI handles the data processing, but a licensed professional makes the final clinical call.

Future Trends in AI-Driven Healthcare

The trajectory of health tech suggests several key trends will define the next era of medicine:

No More Unnecessary Driver's License Suspensions in Utah!
  • Hybrid Clinical Evaluations: A shift toward chatbots that conduct the initial patient intake and evaluation, which are then reviewed by a human doctor.
  • Specialized Medical LLMs: A move away from general AI toward models trained specifically on verified medical literature to reduce “hallucinations” and errors.
  • Stricter Oversight Frameworks: Increased pressure on federal agencies to create a certification process for any AI that can autonomously alter a patient’s medication.

Frequently Asked Questions

Can AI legally prescribe medication?

This is currently a point of intense legal and professional debate. While some regions, like Utah, have experimented with autonomous renewals via startups like Doctronic, medical boards often push back, insisting on physician oversight to ensure patient safety.

Can AI legally prescribe medication?
Utah Medical Safety

Why are hospitals creating their own chatbots instead of using ChatGPT?

Hospitals are implementing proprietary chatbots to provide more controlled, accurate, and secure health information, effectively fighting off the use of general-purpose AI that may not be tailored to specific clinical guidelines.

Who is responsible if an AI doctor makes a mistake?

This remains one of the biggest policy challenges. The tension between the Utah Medical Licensing Board and the state’s AI policy office underscores the uncertainty regarding liability when physician oversight is removed from the process.

What do you think? Would you trust a chatbot to renew your prescriptions, or is human oversight non-negotiable in medicine? Share your thoughts in the comments below or subscribe to our newsletter for more updates on the intersection of health, and technology.

April 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

FDA rejects proposal to deregulate AI devices

by Chief Editor April 10, 2026
written by Chief Editor

Health Tech Correspondent

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

The Expanding Role of AI in Diagnostics

Artificial intelligence is rapidly moving beyond simple automation in healthcare and becoming a core component of diagnostics. We’re seeing AI algorithms now capable of detecting subtle patterns in medical images – X-rays, MRIs, CT scans – that might be missed by the human eye. PathAI, for example, is using AI to assist pathologists in cancer diagnosis, improving accuracy and reducing turnaround times. This isn’t about replacing doctors, but augmenting their abilities.

The trend isn’t limited to imaging. AI is also being deployed to analyze genomic data, predict patient risk scores, and even diagnose conditions based on voice patterns. A recent study published in Nature Medicine showed an AI model accurately diagnosing depression from speech with 89% accuracy. Expect to see more of these ‘digital biomarkers’ emerge.

The Rise of Personalized Digital Therapeutics

Digital therapeutics – software-based interventions used to treat medical conditions – are gaining traction. But the future isn’t just about generic apps. We’re moving towards highly personalized digital therapeutics powered by AI. These programs will adapt to an individual’s needs, preferences, and responses in real-time, maximizing effectiveness.

Pear Therapeutics, a pioneer in the field, has already received FDA clearance for several digital therapeutics. However, the next generation will be far more sophisticated, incorporating continuous monitoring via wearables and integrating with electronic health records for a holistic view of the patient. This level of personalization requires significant computational power and advanced AI algorithms.

Wearables: From Fitness Trackers to Continuous Health Monitoring

Wearable technology has evolved significantly. While initially focused on fitness tracking, wearables are now capable of continuous, multi-parameter health monitoring. The Apple Watch, for instance, can now detect atrial fibrillation and even estimate blood oxygen levels. But this is just the beginning.

Future wearables will incorporate more advanced sensors, capable of monitoring biomarkers in sweat, tears, and even interstitial fluid. Companies like Profusa are developing tiny, implantable sensors that can continuously monitor glucose levels and other vital signs. This data, combined with AI-powered analytics, will enable proactive health management and early disease detection.

Did you understand? The global wearable medical device market is projected to reach $28.2 billion by 2027, according to a report by Grand View Research.

The Metaverse and Virtual Reality in Healthcare

The metaverse, often associated with gaming and social interaction, is finding surprising applications in healthcare. Virtual reality (VR) is being used for pain management, rehabilitation, and even surgical training. XRHealth, for example, offers VR-based therapeutic programs for a range of conditions, from chronic pain to stroke recovery.

The potential extends beyond therapy. VR and augmented reality (AR) can be used to enhance medical education, allowing students to practice complex procedures in a safe and realistic environment. The metaverse could facilitate remote patient consultations and support groups, improving access to care for underserved populations.

Telehealth 2.0: Beyond Video Calls

Telehealth experienced a surge in popularity during the pandemic, but the future of remote care goes far beyond simple video calls. We’re seeing the emergence of “hospital at home” programs, where patients receive acute care in the comfort of their own homes, monitored remotely by healthcare professionals and powered by connected devices.

These programs rely on a combination of telehealth technology, remote patient monitoring, and AI-powered analytics to provide a level of care comparable to that of a traditional hospital setting. Companies like Current Health are leading the way in this space, demonstrating the potential to reduce hospital readmissions and improve patient outcomes.

The Importance of Data Security and Interoperability

As healthcare becomes increasingly reliant on technology, data security and interoperability are paramount. Protecting patient data from cyberattacks is crucial, and ensuring that different healthcare systems can seamlessly exchange information is essential for coordinated care. Blockchain technology is being explored as a potential solution for enhancing data security and interoperability.

FAQ

  • Will AI replace doctors? No, AI is intended to augment the abilities of doctors, not replace them. It will handle repetitive tasks and provide insights to help doctors make more informed decisions.
  • How secure is my health data with these new technologies? Data security is a major concern. Healthcare providers and technology companies are investing heavily in cybersecurity measures to protect patient data.
  • Are digital therapeutics covered by insurance? Coverage varies. Some digital therapeutics are now covered by insurance, but it’s still an evolving landscape.
  • What is the metaverse’s role in healthcare? The metaverse offers opportunities for VR-based therapy, medical education, remote consultations, and patient support groups.

Pro Tip: Stay informed about the latest advancements in health tech by subscribing to industry newsletters and following thought leaders on social media.

Want to learn more about the intersection of technology and healthcare? Sign up for the STAT Health Tech newsletter for bi-weekly updates and in-depth analysis.

April 10, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

ChatGPT & Healthcare: The Rise of AI Chatbots in Patient Journeys

by Chief Editor March 26, 2026
written by Chief Editor

The Rise of the Chatbot Doctor: How AI is Changing Healthcare’s First Point of Contact

The image of a doctor’s office, complete with a slightly passive-aggressive novelty mug warning against self-diagnosis via Google, feels increasingly…quaint. As health tech evolves, the first interaction many people are having about their health isn’t with a physician, but with an AI chatbot. This shift, highlighted in recent reporting, is rapidly reshaping the healthcare landscape.

From Google Searches to Generative AI: A New Era of Self-Triage

For years, the internet has been a primary source of health information – often unreliable. Now, sophisticated chatbots powered by generative AI are stepping in as a more structured, albeit still evolving, first point of contact. People are turning to these tools for initial symptom assessment, basic medical advice, and even emotional support. This trend isn’t necessarily about replacing doctors, but about augmenting access to care and potentially easing the burden on an already strained healthcare system.

The STAT+ Exclusive: Data on Chatbot Usage

Recent data, exclusively available to STAT+ subscribers, reveals the accelerating adoption of health-focused chatbots. While specific details are behind a paywall, the core takeaway is clear: a significant and growing number of individuals are initiating their health journeys with these AI-powered tools. This suggests a fundamental change in patient behavior and expectations.

What’s Driving the Demand? Accessibility and Convenience

The appeal of chatbots is straightforward: they offer 24/7 accessibility, immediate responses, and a degree of privacy that some patients may not experience with traditional healthcare settings. For individuals in remote areas, those with limited mobility, or those simply seeking quick answers to non-emergency questions, chatbots can be a lifeline. The convenience factor is undeniable.

The Role of Health Tech Reporters Like Mario Aguilar

Journalists like Mario Aguilar at STAT are playing a crucial role in covering this rapidly evolving space. Aguilar’s work focuses on the intersection of technology, health, and policy, exploring both the potential benefits and the inherent challenges of integrating AI into healthcare. His reporting provides critical insights into the business and regulatory hurdles that must be overcome to realize the promise of health tech.

Beyond Symptom Checkers: The Expanding Capabilities of AI in Healthcare

Chatbots are just the tip of the iceberg. AI is being deployed across a wide range of healthcare applications, including:

  • Drug Discovery: Accelerating the identification of potential drug candidates.
  • Personalized Medicine: Tailoring treatment plans based on individual patient data.
  • Remote Patient Monitoring: Tracking vital signs and alerting healthcare providers to potential problems.
  • Virtual Reality Therapy: Providing immersive experiences for pain management and mental health treatment.

The Challenges Ahead: Accuracy, Bias, and Regulation

Despite the excitement, significant challenges remain. Ensuring the accuracy and reliability of AI-powered healthcare tools is paramount. Addressing potential biases in algorithms is crucial to avoid exacerbating existing health disparities. And establishing clear regulatory frameworks is essential to protect patient safety and privacy.

Pro Tip:

When using a health chatbot, remember it’s not a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment.

FAQ: AI and Your Health

  • Q: Are health chatbots HIPAA compliant?
    A: Compliance varies. It’s essential to check the chatbot’s privacy policy and ensure it meets HIPAA standards before sharing personal health information.
  • Q: Can AI diagnose medical conditions?
    A: Currently, AI can assist in diagnosis by analyzing symptoms and data, but a final diagnosis should always be made by a qualified healthcare professional.
  • Q: What are the risks of using health chatbots?
    A: Potential risks include inaccurate information, privacy breaches, and over-reliance on AI for critical health decisions.

Did you know? Mario Aguilar similarly hosts a health tech talk show on YouTube, providing another avenue for staying informed about the latest developments in the field.

Explore more articles on health tech and digital therapeutics on STAT News. Learn more here.

March 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Sepsis Cases Rising in Massachusetts: What You Need to Know

by Chief Editor March 22, 2026
written by Chief Editor

The Sepsis Surge: Billing Practices and the Future of Healthcare Diagnostics

Sepsis, a life-threatening condition arising from the body’s overwhelming response to an infection, is increasingly in the spotlight. The condition, likewise known as septicemia or septic shock, can originate from infections in the lungs, bladder, or anywhere else in the body. Massachusetts has seen a significant rise in reported cases, but the question remains: is this a genuine public health crisis, or a consequence of evolving billing practices?

A Tripling of Hospitalizations: What’s Behind the Numbers?

Preliminary state data indicates that hospitalizations for septicemia in Massachusetts have more than tripled since 2010, exceeding 42,000 cases in the year ending September 2025. Since 2019, sepsis has consistently ranked as the third-leading cause of hospitalization in the state. While improved recognition and diagnosis likely contribute to this increase, a growing concern centers on the complex interplay between hospitals, insurers, and the technology they employ.

Experts suggest hospitals are increasingly focused on optimizing billing to counteract insurer denials. This often translates to billing for the most severe conditions patients could conceivably have, based on their symptoms. This practice, fueled by artificial intelligence and other advanced technologies, is adding to healthcare costs without necessarily benefiting patients.

Pro Tip: Understanding your hospital bill is crucial. Don’t hesitate to ask for a detailed itemization and question any charges you don’t understand.

The AI Arms Race in Healthcare Billing

The surge in sepsis diagnoses is occurring alongside a broader trend of sophisticated billing strategies. Both hospitals and insurers are leveraging AI to gain an advantage. Hospitals use it to maximize revenue, while insurers employ it to scrutinize claims and minimize payouts. This creates a “game” where the focus shifts from patient care to financial outcomes.

Don Berwick, a former administrator of the Centers for Medicare and Medicaid Services, highlights this issue, stating that the current healthcare payment system incentivizes revenue maximization, and this has “gotten way out of control.”

Future Trends: Predictive Diagnostics and Value-Based Care

The current situation points to several potential future trends in healthcare:

  • Increased Focus on Early Detection: As awareness of sepsis grows, and with the potential for AI-powered diagnostic tools, People can expect a greater emphasis on early detection and intervention.
  • Shift Towards Value-Based Care: The current fee-for-service model incentivizes volume over value. A move towards value-based care, where providers are rewarded for patient outcomes rather than the number of procedures performed, could mitigate some of the billing pressures.
  • Greater Transparency in Billing: Patients are demanding more transparency in healthcare costs. Expect to see increased efforts to provide clear, understandable billing information.
  • AI-Driven Diagnostic Accuracy: While AI is currently used in billing, its potential for improving diagnostic accuracy is significant. More accurate diagnoses could lead to more appropriate treatment and potentially reduce the need for costly interventions.

The Role of the Massachusetts Sepsis Consortium

The Massachusetts Sepsis Consortium is working to address the fragmented data surrounding sepsis incidence in the Commonwealth. Recognizing sepsis as a major burden on the healthcare system and patients, the consortium aims to improve understanding and ultimately save lives.

FAQ: Sepsis and Hospital Billing

What is sepsis? Sepsis is a life-threatening condition caused by the body’s overwhelming response to an infection.

Is the increase in sepsis cases real? The increase is likely a combination of improved diagnosis and changes in billing practices.

Why are hospital bills so high? Complex billing systems, coupled with the financial incentives within the healthcare system, contribute to high costs.

What can I do if I suspect a billing error? Request a detailed itemization of your bill and contact the hospital’s billing department to discuss any discrepancies.

Did you know? Sepsis can affect anyone, but certain populations, such as infants and the elderly, are at higher risk.

Want to learn more about sepsis and how to protect yourself and your loved ones? Explore resources from Sepsis Smart and the Massachusetts Sepsis Consortium.

Have questions or thoughts on this topic? Share your comments below!

March 22, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Telehealth’s Rural Reach: Mental Health, GLP-1s & AI in Health Tech

by Chief Editor March 12, 2026
written by Chief Editor

The Evolving Landscape of Telehealth: AI, Access, and the Future of Virtual Care

The rapid expansion of telehealth, accelerated by recent events, is undergoing a critical reassessment. While adoption rates have soared, questions are emerging about who truly benefits from this technology and how to ensure equitable access. Recent data suggests the initial boom isn’t translating into improved care for those who need it most, particularly in rural and underserved communities.

Uneven Distribution of Virtual Mental Health Access

A new analysis of Medicare claims data from 2018 through 2023 reveals a concerning trend: mental health providers who readily embraced telehealth aren’t necessarily expanding care to rural and underserved populations. This suggests that telehealth, while widely adopted, isn’t automatically bridging the gap in access. Factors like existing demand in local communities and the need for improved broadband infrastructure and interstate licensing are likely playing a significant role.

This echoes earlier findings that telehealth utilization is higher among individuals with higher incomes, employment, and education levels. The promise of technology expanding access remains unrealized without addressing systemic barriers.

Pro Tip: Facilitating interstate licensing for providers and investing in broadband access are crucial steps toward ensuring telehealth benefits reach those who need it most.

The Rise of “Shadow” Medical Groups and GLP-1 Telehealth

The convenience of telehealth has fueled a surge in demand for medications like GLP-1s for obesity, and diabetes. However, this demand has also attracted scrutiny from the Food and Drug Administration (FDA). A recent analysis reveals that a significant portion of companies marketing compounded GLP-1 medications are affiliated with just four nationwide medical groups – often referred to as “white label” practices.

These medical groups provide the prescribing infrastructure for many telehealth businesses, raising questions about oversight and the potential for misleading marketing practices. As the FDA intensifies its crackdown on compounded drug marketing, these arrangements are coming under increased scrutiny.

AI Agents: The Next Wave of Healthcare Automation

Artificial intelligence (AI) is poised to revolutionize healthcare, and AI agents – software tools capable of autonomously completing tasks like medical coding, documentation, and scheduling – are at the forefront of this transformation. Major players like Epic, Oracle, Amazon, and Microsoft are all introducing new AI agents.

However, this rapid adoption is accompanied by growing concerns about validation and patient input. Recent studies highlight the need for thorough testing and careful consideration of the ethical implications before widespread implementation of AI in healthcare.

Beyond the Headlines: Other Key Developments

Omada’s Path to Profitability and the GLP-1 Opportunity

Digital health company Omada recently posted its first profitable quarter, driven in part by its strategy around GLP-1 medications and the integration of AI. This demonstrates the potential for digital health companies to achieve financial sustainability while addressing pressing healthcare needs.

Google’s AMIE: A Promising Diagnostic Chatbot

Google’s AMIE, a diagnostic chatbot, is showing promising results in real-world clinical settings. A recent study found that AMIE’s suggested diagnoses aligned with the final diagnoses in 90% of cases. Google is now conducting a randomized study of AMIE with Included Health.

Investment and Innovation in Clinical AI

Amigo AI, a developer of patient-facing clinical AI agents, recently raised $11 million in Series A funding. This investment underscores the growing interest in AI-powered tools that can empower patients and improve care coordination.

Interoperability and Data Access

Samsung is partnering with interoperability company B.well to develop health records readily accessible on Samsung smartphones. This initiative aims to improve patient engagement and empower individuals to take control of their health information.

Addressing Fraud with AI

Codoxo, a company using technology to detect healthcare fraud, has launched a “deepfake detection” system to identify AI-generated or manipulated medical documentation. This highlights the emerging challenges of maintaining data integrity in the age of AI.

Expanding Care Models with AI

Sword Health, initially focused on virtual physical therapy, is expanding its offerings to include AI-powered mental health support (Dawn) and cardiometabolic care (Pulse), including support for GLP-1 medications. This demonstrates a trend toward integrated, AI-driven care models.

EHR Integration and Workflow Optimization

EHR vendor Meditech has added ambient listening capabilities to its mobile apps, and video conferencing service Zoom has enhanced its healthcare-focused features, including better integration with Epic. These developments aim to streamline workflows and improve the user experience for clinicians.

Frequently Asked Questions (FAQ)

  • What is telehealth? Telehealth is the delivery of healthcare services via two-way, interactive technology.
  • Is telehealth covered by Medicare? Medicare covers specific Part B services provided through telehealth, substituting for in-person visits.
  • What are AI agents in healthcare? AI agents are software tools that autonomously complete healthcare tasks, such as coding, documentation, and scheduling.
  • Are there limitations to telehealth coverage? Geographic requirements and originating site restrictions have been extended through December 31, 2027.

The future of telehealth is dynamic and complex. As technology continues to evolve, it’s crucial to prioritize equitable access, robust validation, and patient-centered care to ensure that virtual care truly benefits all.

March 12, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Cognito raises $105 million for Alzheimer’s treatment device

by Chief Editor March 5, 2026
written by Chief Editor

Cognito’s $105 Million Raise: A Glimpse into the Future of Neurological Treatment

Cognito Therapeutics’ recent $105 million Series C funding round, led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital, signals growing investor confidence in the potential of non-invasive brain stimulation as a treatment for neurodegenerative diseases. The company, which has now raised $233 million to date, is focused on its Spectris device, a novel approach to addressing conditions like Alzheimer’s disease.

The Spectris Device: How It Works

Spectris, developed from research originating at MIT, utilizes gamma frequency light and sound delivered via a wearable device resembling sunglasses with over-ear headphones. Patients receive a one-hour daily stimulus designed to restore brain activity disrupted by neurodegenerative processes. While clinical trial results are still pending, the substantial investment suggests a belief in the underlying science and potential for FDA clearance.

Beyond Alzheimer’s: Expanding Applications of Sensory Stimulation

Cognito’s work isn’t isolated. The broader field of sensory stimulation is gaining traction, with researchers exploring its applications in a range of neurological and psychiatric conditions. This includes potential treatments for Parkinson’s disease, traumatic brain injury, and even depression. The appeal lies in the non-invasive nature of these therapies, offering a potentially safer alternative to more invasive procedures or pharmaceutical interventions.

The Rise of Digital Therapeutics and Wearable Brain Devices

Cognito’s success is part of a larger trend: the rise of digital therapeutics. These therapies deliver medical interventions directly to patients through software and devices. Wearable brain devices, in particular, are attracting significant investment. The market is driven by an aging population, increasing prevalence of neurological disorders, and a growing demand for personalized medicine.

Challenges and Opportunities in the Field

Despite the promise, several challenges remain. Demonstrating efficacy through rigorous clinical trials is paramount. Regulatory pathways for digital therapeutics are still evolving, creating uncertainty for companies. Ensuring patient adherence to treatment protocols – a daily one-hour session – will be crucial for success. However, the potential rewards are substantial, offering the possibility of improving the lives of millions affected by debilitating neurological conditions.

The Role of AI and Machine Learning in Personalized Stimulation

Future iterations of devices like Spectris are likely to incorporate artificial intelligence and machine learning. AI algorithms could analyze individual patient data – brain activity patterns, cognitive performance, genetic predispositions – to personalize the stimulation parameters. This could optimize treatment efficacy and minimize side effects. Imagine a future where brain stimulation is tailored to each individual’s unique neurological profile.

Investment Trends and the Future Landscape

The $105 million raise for Cognito is indicative of a broader investment trend in health tech. Investors are increasingly recognizing the potential of technology to transform healthcare, particularly in areas with unmet medical needs. Expect to see continued growth in funding for companies developing innovative brain stimulation devices, digital therapeutics, and AI-powered healthcare solutions.

Frequently Asked Questions

  • What is Spectris? Spectris is a sensory stimulus device developed by Cognito Therapeutics, designed to restore brain activity disrupted by neurodegenerative conditions.
  • How does Spectris work? It uses gamma frequency light and sound delivered through a wearable device for one hour daily.
  • What conditions could this technology treat? Currently focused on Alzheimer’s, research suggests potential applications for Parkinson’s disease, traumatic brain injury, and depression.
  • Is this technology widely available? No, This proves still awaiting FDA clearance based on ongoing clinical trial results.

Pro Tip: Keep an eye on developments in digital therapeutics and wearable brain devices. This is a rapidly evolving field with the potential to revolutionize neurological treatment.

Desire to learn more about the intersection of technology and healthcare? Subscribe to the STAT Health Tech newsletter for the latest insights and analysis.

March 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

AI Doctors: Will Artificial Intelligence Replace Physicians?

by Chief Editor February 23, 2026
written by Chief Editor

The AI Doctor is In: How Artificial Intelligence is Poised to Reshape Healthcare

The future of healthcare is rapidly evolving and at the forefront of this transformation is artificial intelligence (AI). What was once the realm of science fiction is now becoming a tangible reality, with AI poised to take on tasks traditionally performed by physicians. This shift isn’t just about automation; it’s about fundamentally changing how healthcare is delivered and accessed.

A Bold Prediction: Will AI Replace Doctors?

Biotech investor Robert Nelsen recently ignited a debate with a provocative claim: AI is not only capable of performing many medical tasks, but is already superior to many doctors. Nelsen shared these views during a live recording of STAT’s “Readout LOUD” podcast, sparking considerable discussion on social media. He later reaffirmed his position on X.

While the idea of AI replacing doctors entirely may seem far-fetched, the increasing capabilities of AI in specific areas are undeniable. The focus isn’t necessarily on complete replacement, but rather on augmentation – AI assisting doctors to improve accuracy, efficiency, and access to care.

AI-Powered Prescription Renewals: A Glimpse into the Future

One concrete example of this shift is Doctronic, a startup utilizing AI to renew prescriptions. In Utah, the company’s chatbot is being permitted to do so, facilitated by a waiver of certain state regulations governing the practice of medicine. This represents a significant step towards integrating AI directly into patient care.

This move raises important questions about the regulatory landscape surrounding AI in healthcare. The argument for why Doctronic’s “AI Doctor” falls outside the Food and Drug Administration’s (FDA) purview is a complex one, and is generating debate among medical experts.

Beyond Prescriptions: Expanding Applications of AI in Healthcare

The potential applications of AI in healthcare extend far beyond prescription renewals. AI algorithms are being developed for:

  • Diagnosis: AI can analyze medical images (X-rays, MRIs, CT scans) to detect anomalies and assist in diagnosis.
  • Drug Discovery: AI is accelerating the drug development process by identifying potential drug candidates and predicting their efficacy.
  • Personalized Medicine: AI can analyze patient data to tailor treatment plans to individual needs.
  • Remote Patient Monitoring: AI-powered devices can monitor patients remotely, alerting healthcare providers to potential problems.

These advancements promise to improve patient outcomes, reduce healthcare costs, and address the growing shortage of healthcare professionals.

Pro Tip: Staying informed about the latest developments in AI and healthcare is crucial for both patients and professionals. Resources like STAT News and industry conferences offer valuable insights.

The Regulatory Tightrope: Balancing Innovation and Patient Safety

As AI becomes more integrated into healthcare, navigating the regulatory landscape will be critical. Striking a balance between fostering innovation and ensuring patient safety is a complex challenge. The FDA and state medical boards are grappling with how to regulate AI-powered medical devices and services.

The case of Doctronic in Utah highlights the need for clear and consistent regulations. Without appropriate oversight, there is a risk of unintended consequences and potential harm to patients.

Frequently Asked Questions

Q: Will AI completely replace doctors?
A: It’s unlikely AI will completely replace doctors, but it will likely augment their abilities and take on many routine tasks.

Q: Is AI in healthcare safe?
A: AI in healthcare has the potential to be highly safe, but it’s crucial to have appropriate regulations and oversight to ensure patient safety.

Q: What are the ethical concerns surrounding AI in healthcare?
A: Ethical concerns include data privacy, algorithmic bias, and the potential for job displacement.

Q: How can I learn more about AI in healthcare?
A: Resources like STAT News, industry conferences, and academic publications can provide valuable information.

Aim for to stay up-to-date on the latest advancements in AI and healthcare? Subscribe to our newsletter for exclusive insights and analysis.

February 23, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Health Tech: AI, VR, Digital Health & the Future of Care

by Chief Editor February 19, 2026
written by Chief Editor

The Expanding Universe of Health Tech: Where is Innovation Heading?

The healthcare landscape is undergoing a rapid transformation, driven by technological advancements. From artificial intelligence to virtual reality, the possibilities seem limitless. But what are the most promising trends, and how will they impact patients and providers in the years to come?

AI: Beyond Diagnosis and Into Personalized Treatment

Artificial intelligence is already making waves in healthcare, particularly in diagnostics. However, the future lies in leveraging AI for truly personalized treatment plans. Which means analyzing vast datasets – including genomic information, lifestyle factors, and medical history – to predict individual responses to therapies and tailor interventions accordingly. Expect to see AI-guided cancer treatments become more sophisticated, as highlighted by Mario Aguilar’s reporting.

The Rise of the Digital Therapeutic

Digital therapeutics – software-based interventions designed to treat medical conditions – are gaining traction. These aren’t just health apps; they’re clinically validated treatments prescribed by healthcare professionals. Areas like mental health, diabetes management, and addiction treatment are seeing significant innovation. The appeal? Increased accessibility, lower costs, and the potential for remote monitoring and support.

Telehealth: From Pandemic Stopgap to Mainstream Care

Telehealth experienced explosive growth during the pandemic, and while usage may have stabilized, it’s here to stay. The future of telehealth isn’t simply replicating in-person visits online. It’s about creating hybrid care models that combine the convenience of virtual consultations with the necessity of physical examinations. Remote patient monitoring, powered by wearable devices, will play a crucial role in this evolution.

Wearable Tech: More Than Just Fitness Trackers

Wearable devices are evolving beyond step counting and heart rate monitoring. They’re becoming sophisticated diagnostic tools, capable of detecting early signs of illness. For example, the Apple Watch’s hypertension alert, while imperfect, demonstrates the potential of wearables to proactively identify health risks. Expect to see more wearables incorporating advanced sensors to monitor a wider range of biomarkers.

VR/AR: Immersive Experiences for Healing and Training

Virtual and augmented reality are finding applications in areas like pain management, rehabilitation, and surgical training. VR can distract patients from pain during procedures, while AR can overlay digital information onto the real world to assist surgeons during complex operations. These immersive technologies offer unique opportunities to enhance both patient care and medical education.

Pro Tip: Staying informed about the latest health tech developments is crucial for both healthcare professionals and patients. Resources like STAT’s Health Tech newsletter, co-authored by Mario Aguilar, can provide valuable insights.

The Data Privacy Challenge

As healthcare becomes increasingly data-driven, protecting patient privacy is paramount. Robust security measures and adherence to regulations like HIPAA are essential. The development of privacy-preserving technologies, such as federated learning, will be critical to unlocking the full potential of health tech while safeguarding sensitive information.

Frequently Asked Questions

What is a digital therapeutic?
A digital therapeutic is a software-based treatment for a medical condition, clinically validated and prescribed by a healthcare professional.
How is AI being used in healthcare?
AI is used in diagnostics, personalized treatment planning, drug discovery, and administrative tasks.
Is telehealth here to stay?
Yes, telehealth is expected to remain a significant part of the healthcare landscape, evolving into hybrid care models.

Want to learn more about the intersection of technology and healthcare? Explore more articles on STAT News and stay up-to-date on the latest innovations.

February 19, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Health Tech: AI, VR, Telehealth & Digital Therapeutics Coverage

by Chief Editor February 17, 2026
written by Chief Editor

The Expanding Horizon of Health Tech: Beyond Wearables and AI

The intersection of technology and healthcare is rapidly evolving, moving beyond simple tracking devices and into areas that promise to fundamentally reshape how we approach wellness and disease management. Mario Aguilar, health tech correspondent at STAT, is at the forefront of covering these changes, focusing on the business and policy implications alongside the technological advancements.

The Rise of Digital Therapeutics

While wearable technology like the Apple Watch has garnered attention for its potential in monitoring conditions like Parkinson’s disease, a significant trend is the development of digital therapeutics. These aren’t just apps that track data. they’re evidence-based, clinically evaluated software programs designed to treat medical conditions. Aguilar’s reporting highlights how companies are seeking FDA clearance for these technologies, signaling a shift towards regulated digital health interventions.

AI’s Role: From “Safe” to “Responsible”

Artificial intelligence is no longer a futuristic concept in healthcare; it’s being implemented in diagnostics, drug discovery, and personalized medicine. However, as Aguilar points out, the conversation needs to shift from simply asking if AI is “safe” to determining if it is “responsible.” This encompasses ethical considerations, data privacy, and ensuring equitable access to these technologies.

Telehealth’s Continued Evolution

Telehealth experienced a surge in adoption, and while some of the initial pandemic-driven growth has leveled off, its role in healthcare delivery is solidified. The focus is now on refining telehealth models, integrating them seamlessly with in-person care, and addressing issues like reimbursement and digital literacy.

Virtual and Augmented Reality in Healthcare

Virtual reality (VR) and augmented reality (AR) are finding niche but impactful applications in healthcare. From training surgeons to providing pain management and rehabilitation therapies, these immersive technologies offer unique possibilities. Aguilar’s coverage extends to these emerging areas, exploring their potential to improve patient outcomes and healthcare efficiency.

The Policy and Business Challenges

Technological innovation alone isn’t enough. Aguilar’s work emphasizes the crucial role of policy and business models in realizing the promise of health tech. Questions around data security, reimbursement, and regulatory pathways are central to the successful adoption of these technologies.

Pro Tip: Staying informed about the regulatory landscape is crucial for anyone involved in health tech. The FDA’s approach to digital health is constantly evolving.

The STAT Health Tech Newsletter

For those seeking a deeper dive into these topics, Aguilar co-authors the STAT Health Tech newsletter, a valuable resource for staying up-to-date on the latest developments in the field.

Frequently Asked Questions

  • What types of technology does Mario Aguilar cover? He covers artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.
  • Where can I find Mario Aguilar’s work? His articles are published on STAT News, and he also co-authors the STAT Health Tech newsletter.
  • What is the focus of Aguilar’s reporting? He explores how technology is changing healthcare practice and the business and policy challenges involved.

Seek to learn more about the future of health technology? Explore more articles on STAT News and subscribe to the STAT Health Tech newsletter for regular updates.

February 17, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

TrumpRx: Are the Drug Prices Really the Lowest?

by Chief Editor February 9, 2026
written by Chief Editor

TrumpRx: A Discount Drug Platform or Just a Clever Illusion?

WASHINGTON — President Trump’s recently launched TrumpRx website promises the “lowest prices anywhere in the world” for prescription drugs. Though, a closer look reveals a more complex picture. Whereas the platform offers discounts on 43 brand-name drugs, a significant portion – at least 22 – already have cheaper generic alternatives available through platforms like GoodRx and Mark Cuban’s Cost Plus Drugs.

The Promise and the Reality of TrumpRx

The Trump administration unveiled TrumpRx as a key component of its plan to lower drug prices and address growing concerns about healthcare affordability. President Trump proclaimed the launch as “the largest reduction in prescription drug prices in history.” The platform doesn’t directly sell medications. instead, it displays cash prices and directs consumers to pharmacies or drug manufacturers.

The core of TrumpRx relies on voluntary “most favored nation” agreements with pharmaceutical companies like Pfizer, Eli Lilly, and Novo Nordisk, aiming to secure prices comparable to those paid in other developed countries. However, experts question whether this approach truly benefits consumers, particularly when generic options exist.

Generics vs. Brand Names: A Costly Choice?

STAT’s analysis highlights a critical issue: many drugs available on TrumpRx have significantly cheaper generic equivalents. For instance, Pfizer’s Protonix, used for acid reflux, is listed at $200 for a 30-pack on TrumpRx, while the same dosage and quantity of the generic version costs around $6 at Cost Plus Drugs. Similar discrepancies exist for other medications, potentially costing consumers hundreds of dollars.

Mark Cuban, founder of Cost Plus Drugs, acknowledged the situation, stating on X (formerly Twitter), “They added a bunch of brands that have generics. So we beat them there. Usually by a lot.” Despite this, he praised TrumpRx’s lower prices for certain drugs, like those used in fertility treatments, calling it a “positive step forward.”

Concerns and Criticisms from Democrats

Senate Democrats have been vocal in their criticism of TrumpRx, labeling it a “vanity project” and raising concerns about potential conflicts of interest involving the pharmaceutical industry and the Trump family. Democratic Health Committee leaders have as well questioned the transparency of the pricing agreements with drug manufacturers, noting that the terms remain undisclosed to the public.

Senator Ron Wyden (D-OR) dismissed TrumpRx as a “glorified coupon book,” suggesting it offers limited real value to patients. These criticisms underscore the broader debate about the effectiveness of direct-to-consumer drug programs and their impact on overall healthcare costs.

Beyond the Discounts: What’s the Bigger Picture?

Experts point out that cash prices, even with discounts, are often higher than what patients pay through their insurance plans. These cash purchases don’t contribute to deductibles or out-of-pocket maximums. The White House has added a disclaimer to TrumpRx advising insured consumers to check their insurance coverage first, but no such guidance exists for generic alternatives.

The administration defends the program, stating that TrumpRx focuses on branded products, particularly those lacking generic counterparts, such as GLP-1s used for weight loss and diabetes. Drug manufacturers like Eli Lilly and Novo Nordisk have already lowered cash prices for these medications in deals with the White House.

What to know about TrumpRx, the Trump administration’s prescription drug platform

Future Trends and the Path Forward

The launch of TrumpRx highlights the ongoing struggle to balance drug affordability with pharmaceutical innovation. Direct-to-patient programs are likely to become more prevalent, filling gaps in insurance coverage and offering alternative purchasing options. However, ensuring transparency and guiding consumers toward the most cost-effective choices – including generics – will be crucial.

The success of TrumpRx will depend on its ability to deliver genuine savings, particularly for drugs without generic alternatives. Continued negotiations with pharmaceutical companies and a focus on addressing the root causes of high drug prices will be essential for achieving lasting change.

Frequently Asked Questions (FAQ)

  • What is TrumpRx? TrumpRx is a website launched by the Trump administration designed to help uninsured Americans find discounted prices for brand-name prescription drugs.
  • Does TrumpRx sell drugs directly? No, TrumpRx displays prices and directs consumers to pharmacies or drug manufacturers to make purchases.
  • Are there cheaper alternatives to the drugs on TrumpRx? Yes, many drugs listed on TrumpRx have cheaper generic equivalents available.
  • What are Democrats saying about TrumpRx? Democrats have criticized TrumpRx, calling it a “vanity project” and raising concerns about potential conflicts of interest.

Pro Tip: Before using TrumpRx, always check with your insurance provider to see if you can get a lower price through your plan. Also, compare prices with GoodRx and Cost Plus Drugs to ensure you’re getting the best deal.

Did you know? The White House has added a disclaimer to TrumpRx advising insured consumers to check their insurance coverage, but no such guidance exists for generic alternatives.

What are your thoughts on TrumpRx? Share your experiences and opinions in the comments below!

February 9, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Wing Tai, Metro outbid 5 others for Dunearn Road site with bullish S$1,625 psf ppr bid at just under S$533 million

    April 28, 2026
  • My parents ran one of those houses where the door was always open

    April 28, 2026
  • Ty Simpson Reveals Secret Pre-Draft Meeting With Sean McVay

    April 28, 2026
  • Malaria Funding Crisis And Drug Resistance Compel African Investment

    April 28, 2026
  • Neanderthal brains measure up to ours—literally

    April 28, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World